explore -WSS

explore

author：fashion 2025-08-28 03:35:00 - browse：44284

A sign of Gilead Sciences sits in front of its headquarter and next to a pedestrian crossing sign — health coverage from STAT — Justin Sullivan/Getty Images

The assault on the development of new lifesaving therapies continues apace. Recently, the First Appellate Division of California Appeals held that companies not only have to defend products they have developed and marketed, but also those they have not.

In 2001, Gilead secured FDA approval of tenofovir disoproxil fumarate (TDF), one of first medicines to treat HIV — a product still on the market, despite the potential side effect of causing skeletal and kidney damage. In the years that followed, the company invested in research leading to additional TDF-based regimens critical to the fight against HIV. It had also done preliminary work on a similar but different drug — tenofovir alafenamide fumarate (TAF) — for which it had early, although not definitive, evidence for safety and efficacy.

Ultimately, this medicine was shown to have a better side effect profile than TDF. Starting in 2018, plaintiffs began suing Gilead for negligently failing to develop TAF earlier, on the theory that it wanted to protect the profits from TDF. Now, the California court has agreed to let the suit proceed.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Novo Nordisk touts Wegovy study, but still struggling with supply

WSS

Be careful with at

Health AI: on the border between health care and tech

Eight reasons why you should get an updated Covid vaccine

Female surgeons have lower rates of long

What's changing in Medicare's open enrollment this year?

Biden administration begins canceling student loan debt for 804,000 borrowers

hotspot

explore

focus

Supreme Court strikes down use of affirmative action

How doctors and nurses shape Google's AI

Activists slam private health insurers over coverage restrictions

Montana youths win climate lawsuit against state for promoting fossil fuels

Novavax promises a turnaround & Lilly roils the obesity market

Megan Rapinoe shares emotional post following US Women's World Cup exit

In Memoriam: Notable people who died in 2023

Life sciences deals on track to hit lowest point since 2017

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Better Therapeutics data on benefit with GLP

knowledge

There’s no way to know how good AI health technologies are

Dozens dead from Maui wildfires: What we know about the victims

Judge sides with young activists in first

Novo Nordisk touts Wegovy study, but still struggling with supply

https://cbu01.alicdn.com/img/ibank/2017/940/343/4292343049_1422730631.220x220xz.jpg

Indictment alleges Trump's ex

entertainment

focus

hotspot

hotspot